It is thus important to develop tools that help to better differentiate MOG‐EM from MS, in particular as this harbors therapeutic implications: MS can be treated with several immunotherapies, but MOG‐EM may not only not respond, but even worsen under established MS treatments.13, 14. Here, MOG is linked to myeloid sarcoma.